Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic
- PMID: 20016036
- PMCID: PMC2888158
- DOI: 10.1099/vir.0.017459-0
Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic
Abstract
Pandemic influenza viruses can emerge through continuous evolution and the acquisition of specific mutations or through reassortment. This study assessed the pandemic potential of H5N1 viruses isolated from poultry outbreaks occurring from July 2006 to September 2008 in the Lao People's Democratic Republic (PDR). We analyzed 29 viruses isolated from chickens and ducks and two from fatal human cases in 2007. Prior to 2008, all H5N1 isolates in Lao PDR were from clade 2.3.4; however, clade 2.3.2 was introduced in September 2008. Of greatest concern was the circulation of three isolates that showed reduced sensitivity to the neuraminidase (NA) inhibitor oseltamivir in an enzyme inhibition assay, each with different NA mutations - V116A, I222L and K150N, and a previously unreported S246N mutation. In addition, six isolates had an S31N mutation in the M2 protein, which conferred resistance to amantadine not previously reported in clade 2.3.4 viruses. Two H5N1 reassortants were isolated whose polymerase genes, PB1 and PB2, were homologous to those of Eurasian viruses giving rise to a novel H5N1 genotype, genotype P. All H5N1 viruses retained avian-like receptor specificity, but four had altered affinities for alpha2,3-linked sialic acid. This study shows that, in a genetically similar population of H5N1 viruses in Lao PDR, mutants emerged with natural resistance to antivirals and altered affinities for alpha2,3-linked sialic acids, together with reassortants with polymerase genes homologous to Eurasian viruses. These changes may contribute to the emergence of a pandemic influenza strain and are critical in devising surveillance strategies.
Figures




Similar articles
-
Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets.PLoS Pathog. 2010 May 27;6(5):e1000933. doi: 10.1371/journal.ppat.1000933. PLoS Pathog. 2010. PMID: 20523902 Free PMC article.
-
Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.Antiviral Res. 2013 May;98(2):297-304. doi: 10.1016/j.antiviral.2013.02.013. Epub 2013 Feb 28. Antiviral Res. 2013. PMID: 23458714 Free PMC article.
-
Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses.PLoS Pathog. 2008 Apr 11;4(4):e1000043. doi: 10.1371/journal.ppat.1000043. PLoS Pathog. 2008. PMID: 18404209 Free PMC article.
-
[Analysis of decrease in sensitivity in influenza A (H5N1) avian and human strains to neuraminidase inhibitors].Rev Esp Quimioter. 2008 Mar;21(1):32-6. Rev Esp Quimioter. 2008. PMID: 18443931 Review. Spanish.
-
Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance.Influenza Other Respir Viruses. 2013 Jan;7 Suppl 1(Suppl 1):25-36. doi: 10.1111/irv.12047. Influenza Other Respir Viruses. 2013. PMID: 23279894 Free PMC article. Review.
Cited by
-
Ancestral and Compensatory Mutations that Promote Antiviral Resistance in Influenza N1 Neuraminidase Revealed by a Phylonumerics Approach.J Mol Evol. 2018 Oct;86(8):546-553. doi: 10.1007/s00239-018-9866-4. Epub 2018 Oct 9. J Mol Evol. 2018. PMID: 30302501
-
Evolutionary and Mutational Characterization of the First H5N8 Subtype Influenza A Virus in Humans.Pathogens. 2022 Jun 8;11(6):666. doi: 10.3390/pathogens11060666. Pathogens. 2022. PMID: 35745520 Free PMC article.
-
Isolation of Highly Pathogenic H5N1 Influenza Viruses in 2009-2013 in Vietnam.Front Microbiol. 2019 Jun 25;10:1411. doi: 10.3389/fmicb.2019.01411. eCollection 2019. Front Microbiol. 2019. PMID: 31293548 Free PMC article.
-
Emerging influenza antiviral resistance threats.J Infect Dis. 2011 Jan 1;203(1):6-10. doi: 10.1093/infdis/jiq012. J Infect Dis. 2011. PMID: 21148489 Free PMC article. No abstract available.
-
A novel immunochromatographic system for easy-to-use detection of group 1 avian influenza viruses with acquired human-type receptor binding specificity.Biosens Bioelectron. 2015 Mar 15;65:211-9. doi: 10.1016/j.bios.2014.10.036. Epub 2014 Oct 22. Biosens Bioelectron. 2015. PMID: 25461160 Free PMC article.
References
-
- Cheung, C. L., Rayner, J. M., Smith, G. J., Wang, P., Naipospos, T. S., Zhang, J., Yuen, K. Y., Webster, R. G., Peiris, J. S. & other authors (2006). Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis 193, 1626–1629. - PubMed
-
- de Jong, M. D., Tran, T. T., Truong, H. K., Vo, M. H., Smith, G. J., Nguyen, V. C., Bach, V. C., Phan, T. Q., Do, Q. H. & other authors (2005). Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353, 2667–2672. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous